This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Market Morning: Another 'Merkozy' Meeting

NEW YORK ( TheStreet) -- U.S. stock futures were flat early Monday ahead of the latest meeting of "Merkozy" -- German Chancellor Angela Merkel and French President Nicolas Sarkozy are meeting to discuss ways to boost growth as debt fears in the eurozone once again linger.

European stocks were higher, getting a boost from a rise in German exports.

Asian stocks finished higher Monday. The benchmark Shanghai Composite Index gained 2.9% to 2,225.89, while the Hang Seng in Hong Kong rose 1.5%. Markets in Japan were closed.

U.S. stocks finished last week, the first trading week of 2012, with solid gains. The Dow Jones Industrial Average on Friday settled down 56 points, or 0.5%, to 12,360 but posted a gain of more than 1% for the week.

The S&P 500 dropped 3 points, or 0.3%, to 1,278, putting the index 1.6% ahead for the week. The Nasdaq tacked on 4 points, or 0.2%, to 2,674 on Friday, and posted a 2.7% gain for the week.


The economic calendar in the U.S. includes the Conference Board's employment trend index for December at 10 a.m. EST. The Federal Reserve is scheduled to issue consumer credit data at 3 p.m.


Alcoa (AA - Get Report) posts results after the closing bell Monday, marking the unofficial start to the earnings season.

The aluminum maker last week said its global smelting capacity will be reduced by 12% after the closure of certain plants. Alcoa said it would record fourth-quarter restructuring charges of $155 million to $165 million.

Analysts' expectations on Alcoa's results vary from a loss of 5 cents a share to a profit of 1 cent.


Bristol-Myers Squibb (BMY - Get Report) plans to acquire Inhibitex (INHX) for $2.5 billion.

Bristol-Myers' all-cash tender offer values Inhibitex at $26 a share, or more than two-and-a-half times the company's closing stock price on Friday of $9.87.

For all that cash, Bristol-Myers gains control of Inhibitex's INX-189, a pill in phase II studies which has the potential to become a component in the first all-oral therapies against hepatitis C.


-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AA $11.03 -0.63%
BMY $67.53 0.07%
AAPL $126.16 -0.22%
FB $87.60 0.36%
GOOG $522.84 -0.11%

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs